This was the stock's second consecutive day of losses.

KKR posted fourth-quarter net income growth as lower expenses offset a drop in revenue, and assets under management at the buyout firm grew as it prepared for a potential deal bonanza in the second ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

Securities updated their financial outlook on Henry Schein (NASDAQ:HSIC), increasing the price target to $78 from the previous $75, while maintaining a Neutral rating on the company's stock. According ...

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...